Opioid reward mechanisms: A key role in drug abuse?

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 3, 1998, Pages 252-258

  Herz, Albert ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Alcohol; Endogenous opioid systems; Psychostimulants; Reward mechanisms

Indexed keywords

ALCOHOL; COCAINE; DELTA OPIATE RECEPTOR; ENDORPHIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALTREXONE; OPIATE; OPIATE ANTAGONIST; PSYCHOSTIMULANT AGENT;

ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR; DOPAMINE RELEASE; DRUG ABUSE; DRUG WITHDRAWAL; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR DENSITY; SENSITIZATION;

EID: 0031868504     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y98-017     Document Type: Article

References (70)

1. Acquas, E., and DiChiara, G.D. 1992. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58: 1620-1625.
2. Acquas, E., Carboni, E., Leone, P., and DiChiara, G.D. 1991. Profound depression of mesolimbic dopamine release after morphine in dependent rats. Eur. J. Pharmacol. 193: 133-134.
3. Acquas, E., Meloni, M., and DiChiara, G. 1993. Blockade of δ-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur. J. Pharmacol. 230: 239-241.
4. Altshuler, H.L., Phillips, P.E., and Feinhandler, D.A. 1980. Alteration of ethanol self-administration by naltrexone. Life Sci. 26: 679-688.
5. Babbini, M., Gaiardi, M., and Bartoletti, M. 1975. Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment. Neuropharmacology, 14: 611-621.
6. Bals-Kubik, R., Herz, A., and Shippenberg, T.S. 1989. Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated. Psychopharmacology, 98: 203-206.
7. Bals-Kubik, R., Herz, A., and Shippenberg, T.S. 1990. Involvement of μ- and δ-receptors in mediating the reinforcing effects of β endorphin in the rat. Eur. J. Pharmacol. 175: 63-69.
8. Bals-Kubik, R., Ableitner, A., Herz, A., and Shippenberg, T.S. 1993. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264: 489-495.
9. DeWaele, J.-P., Kiianmaa, K., and Gianoulakis, C. 1994. Spontaneous and ethanol-stimulated in vitro release of β-endorphin by the hypothalamus of AA and ANA rats: alcoholism. Clin. Exp. Res. 18: 1468-1473.
10. DeWaele, J.-P., Kiianmaa, K., and Gianoulakis, C. 1995. Distribution of the μ and δ opioid binding sites in the brain of the alcohol-preferring AA and alcohol-avoiding ANA lines of rats. J. Pharmacol. Exp. Ther. 275: 518-527.
11. DiChiara, G., and Imperato, A. 1988. Drugs abused by humans preferentially increase synaptic dopamine release in the nucleus accumbens and dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244: 1067-1080.
12. DiChiara, G., and North, R.A. 1992. Neurobiology of drug abuse. TIPS (Trends Pharmacol. Sci.), 13: 185-191.
13. Dole, V.P., and Nyswander, M.E. 1967. Heroin addiction - a metabolic disease. Arch. Intern. Med. 120: 19-24.
14. Dum, J., and Herz, A. 1987. Opioids and motivation. Interdiscip. Sci. Rev. 12: 180-189.
15. Froehlich, J.C., Zweifel, M., Harts, J., Lumeng, L., and Li, T.-K. 1995. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology, 103: 467-472.
16. George, F.R., and Goldberg, S.R. 1989. Genetic approaches to the analysis of addiction processes. TIPS (Trends Pharmacol. Sci.), 10: 78-83.
17. George, S.R., Fan, T., Ng, G.Y.K., Jung, S.Y., O'Dowd, B.F., and Naranjo, C.A. 1995. Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine. J. Pharmacol. Exp. Ther. 273: 373-379.
18. Gianoulakis, C. 1993. Endogenous opioids and excessive alcohol consumption. J. Psychiatry Neurosci. 18: 148-156.
19. Glick, S.D., Maisonneuve, I.H., Roucci, J., and Archer, S. 1995. κ-Opioid inhibition of morphine and cocaine self-administration in rats. Brain Res. 681: 147-152.
20. Goldstein, A. 1983. Some thoughts about endogenous opioids and addiction. Drug Alcohol Depend. 11: 11-14.
21. Grisel, J.E., Grahame, N.J., Mogil, J.S., Belknap, J.K., and Low, M.J. 1995. Decreased voluntary ethanol consumption in transgenic mice lacking β-endorphin. Soc. Neurosci. Abstr. 21: 1699.
22. Gysling, K., and Wang, R.Y. 1983. Morphine-induced activation of AlO dopamine neurons in the rat. Brain Res. 277: 119-127.
23. Heidbreder, C.A., and Shippenberg, T.S. 1996. Direct administration of κ-agonists into the nucleus accumbens prevents the development of behavioural sensitization to cocaine. Soc. Neurosci. Abstr. 22: 929.
24. Heidbreder, C.A., Babovic-Vusanovic, D., Shoaib, M., and Shippenberg, T.S. 1995. Development of behavioural sensitization to cocaine: influence of κ-opioid receptor agonists. J. Pharmacol. Exp. Ther. 275: 150-153.
25. Heijna, M.H., Padt, M., Hagenboom, F., Portoghese, P.S., Mulder, A.H., and Schoffelmeer, A.N.M. 1990. Opioid receptor mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmacol. 18: 267-278.
26. Herz, A. 1997. Endogenous opioid systems and alcohol addiction. Psychopharmacology, 129: 99-111.
27. Hurd, Y., and Nylander, I. 1996. In vivo cocaine affects mesolimbic dynorphin levels. Soc. Neurosci. Abstr. 22: 1881.
28. Hyman, S.E. 1996. Minireview. Addiction to cocaine and amphetamine. Neuron, 16: 901-904.
29. Hyytiå, P. 1993. Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol. Biochem. Behav. 45: 697-701.
30. Hyytiå, P., and Sinclair, J.D. 1993. Oral etonitazene and cocaine consumption by AA, ANA and wistar rats. Psychopharmacology, 111: 409-414.
31. Johnson, S.W., and North, R.A. 1992. Two types of neurones in the ventral tegmental area and their synaptic input. J. Physiol. (London), 450: 455-468.
32. Kalivas, P.W., and Stewart, J. 1991. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244.
33. 10 dopamine neurons by γ-aminobutyric acid agonists. J. Pharmacol. Exp. Ther. 253: 858-866.
34. Koob, G.F. 1996. Drug addiction: the yin and yang of hedonic homeostasis. Neuron, 16: 893-896.
35. Kuhar, M., Ritz, M.C., and Boja, J. 1991. The dopamine hypothesis of reinforcing properties of cocaine. Trends Neurosci. 14: 299-302.
36. Latimer, L.G., Duffy, P., and Kalivas, P.W. 1987. μ-Opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241: 328-337.
37. Magnan, J., Paterson, S.J., Tavani, A., and Kosterlitz, H.W. 1982. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch. Pharmacol. 319: 197-205.
38. Maldonado, R., Saiardi, A., Valverde, O., Samad, T.A., Roques, B.P., and Borrelli, E. 1997. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature (London), 388: 580-589.
39. Matthes, H.W.D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, O., Dierich, A., Le Meurs, M., Dellé, P., Tzavava, E., Hanoune, J., Roques, B., and Kieffer, B. 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid rceptor gene. Nature (London), 383: 819-823.
40. Mucha, R.F., and Herz, A. 1985. Motivational properties of κ- and μ-opioid receptor agonists studied with place and taste preference conditioning procedure. Psychopharmacology, 86: 274-280.
41. Mucha, R.F., Millan, M.J., and Herz, A. 1985. Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central ß-endorphin. Psychopharmacology, 86: 281-285.
42. Nylander, I., Hyytiä, P., Forsander, O., and Terenius, L. 1994. Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol. Clin. Exp. Res. 18: 1272-1279.
43. O'Malley, S., Jaffe, A.J., Chang, G., Schottenfield, R.S., Meyer, R.E., and Rounsaville, B. 1992. Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry, 49: 881-887.
44. Pfeiffer, A., Brantl, V., Herz, A., and Emrich, H.G. 1986. Psychotomimesis mediated by κ-opiate receptors. Science (Washington, D.C.), 233: 774-776.
45. Przewłocka, B., Turchan, J., Lasón, W., and Przewłocki, R. 1996. The effect of single and repeated morphine administration and the prodynorphin system activity in the nucleus accumbens and striatum of the rat. Neuroscience, 70: 749-754.
46. Reid, L., Glick, D., Menkens, K.A., French, E.D., Bilsky, E.J., and Porreca, F. 1995. Cocaine self-administration and naltrindole: a δ-selective opioid antagonist. NeuroReport, 6: 1409-1412.
47. Robinson, T.E., and Berridge, K.C. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291.
48. Rossetti, L.L., Hamaidan, Y., and Gessa, G.L. 1992. Marked inhibition of mesolimbic dopamine release, a common feature of ethanol, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221: 226-234.
49. Shippenberg, T.S., and Heidbreder, C. 1995a. Sensitization to the conditoned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 273: 808-815.
50. Shippenberg, T.S., and Heidbreder, C. 1995b. The δ-opioid antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur. J. Pharmacol. 280: 55-61.
51. Shippenberg, T.S., Emmett-Oglesby, M.W., Ayesta, F.J., and Herz, A. 1988a. Tolerance and selective cross-tolerance to the motivational effects of opioids. Psychopharmacology. 96: 110-115.
52. Shippenberg, T.S., Stein, C., Huber, A., Millan, M.J., and Herz, A. 1988b. Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration of the effects of κ- but not μ-receptor agonists. Pain, 35: 179-186.
53. Shippenberg, T.S., Bals-Kubik, R., and Herz, A. 1993. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptor. J. Pharmacol. Exp. Ther. 65: 53-59.
54. Shippenberg, T.S., Heidbreder, C., and Lefevour, A., 1996. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur. J. Pharmacol. 299: 33-39.
55. Spanagel, R. 1995. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav. Brain Res. 70: 37-49.
56. Spanagel, R., and Shippenberg, T.S. 1993. Modulation of morphineinduced sensitization by endogenous κ-opioid systems in the rat. Neurosci. Lett. 153: 232-236.
57. Spanagel, R., Herz, A., and Shippenberg, T.S. 1990a. Identification of the opioid receptor types mediating β-endorphin-induced alterations in dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 190: 177-184.
58. Spanagel, R., Herz, A., and Shippenberg, T.S. 1990b. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in-vivo microdialysis study. J. Neurochem. 55: 1734-1740.
59. Spanagel, R., Herz, A., and Shippenberg, T.S. 1992. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89: 2040-2050.
60. Spangler, R., Zhou, Y., Maggos, C.E., Schlussman, S.D., Ho, A., and Kreek, M.J. 1997. Prodynorphin, proenkephalin and κ-opioid receptor mRNA responses to acute "binge" cocaine. Mol. Brain Res. 15: 139-142.
61. Spealman, R.D., and Bergman, J. 1992. Modulation of the discriminative stimulus effects by cocaine and by μ-and κ-opioids. J. Pharmacol. Exp. Ther. 261: 607-615.
62. Stein, L., and Belluzzi, J.D. 1977. Brain endorphins: possible mediation of pleasurable states. In Endorphins in mental health research. Edited by E. Usdin, W.E. Bunney, and N.S. Kline. Macmillan, London, pp. 375-389.
63. Steiner, H., and Gerfen, C. 1993. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13: 5066-5081.
64. Steiner, H., and Gerfen, C. 1995. Dynorphin opioid inhibition of cocaine-induced D1 dopamine receptor-mediated immediate-early gene expression. J. Comp. Neurol. 353: 200-212.
65. Terenius, L. 1994. Reward and its control by dynorphin peptides. In Toward a molecular basis of alcohol use and abuse. Edited by B. Jansson, H. Jörnvall, U Rydberg, L. Terenius, and B.L. Vallee. Birkhäuser, Basel, pp. 9-17.
66. Unterwald, E.M., Rubenfeld, J.M., and Kreek, M.J. 1994. Repeated cocaine administration upregulates κand μ-, but not δ-opioid receptors. NeuroReport, 5: 1613-1616.
67. Volpicelli, J.R., Alterman, A.I., Hayashida, M., and O'Brien, C.R. 1992. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry, 49: 876-879.
68. Wise, R.A., and Bozarth, M.A. 1982. Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol. Biochem. Behav. 17: 239-243.
69. Wise, R.A., and Rompre, P.P. 1989. Brain dopamine and reward. Annu. Rev. Psychol. 40: 191-225.
70. Xi, Z.-X., Fuller, S.A., and Stein, E.A. 1996. Interaction between μand κ-opioid agonists on dopamine release in the accumbens during heroin self-administration. An in vivo electrochemical study. Proceedings of the 27th Meeting of the International Narcotics Research Conference, July 21-26, 1996, Long Beach, Calif. p. 51.